awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q46005728-2B01E9C6-80CD-4E0C-9020-9C7D59087EC3
Q46005728-2B01E9C6-80CD-4E0C-9020-9C7D59087EC3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46005728-2B01E9C6-80CD-4E0C-9020-9C7D59087EC3
Which B-cell subset should we target in lupus?
P2860
Q46005728-2B01E9C6-80CD-4E0C-9020-9C7D59087EC3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46005728-2B01E9C6-80CD-4E0C-9020-9C7D59087EC3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1c18a1d1644f826d124b9ba69d8cfb47f85a4816
P2860
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.